Publications in collaboration with researchers from Universidad de Antioquia (26)

2017

  1. Effectiveness of the Dader method for pharmaceutical care on patients with bipolar I disorder: Results from the EMDADER-TAB study

    Journal of Managed Care and Specialty Pharmacy, Vol. 23, Núm. 1, pp. 74-84

  2. Free software to analyse the clinical relevance of drug interactions with antiretroviral agents (SIMARV®) in patients with HIV/AIDS

    Research in Social and Administrative Pharmacy, Vol. 13, Núm. 4, pp. 831-839

2016

  1. Fiabilidad y validez externa de un cuestionario de conocimiento sobre riesgo y enfermedad cardiovascular en pacientes que acuden a farmacias comunitarias de España

    Atencion Primaria, Vol. 48, Núm. 9, pp. 586-595

  2. Relevancia clínica de las interacciones medicamentosas en pacientes infectados con el virus de LA inmunodeficiencia humana: Actualización 2009-2014

    Revista Chilena de Infectologia, Vol. 33, pp. S36-S53

2015

  1. Effectiveness of the dader method for pharmaceutical care in patients with bipolar i disorder: Emdader-tabi: Randomized controlled trial

    Vitae

  2. Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 5, pp. 931-940

2014

  1. Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: Study protocol for a randomized controlled trial

    Trials, Vol. 15, Núm. 1

2013

  1. Effectiveness of pharmacotherapy follow-up for the control of hypertensive patients in community pharmacies: EMDADER-HTA study

    Latin American Journal of Pharmacy, Vol. 32, Núm. 7, pp. 982-988

2012

  1. Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial

    Journal of Managed Care Pharmacy, Vol. 18, Núm. 4, pp. 311-323

  2. Research and publish in pharmaceutical care: A mission for improve and develop

    Vitae

2011

  1. Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)

    Atencion Primaria, Vol. 43, Núm. 5, pp. 245-253

  2. Investigación en atención farmacéutica: Una necesidad con ciertos requisitos

    Atencion Farmaceutica

  3. Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR study

    American Journal of Hypertension, Vol. 24, Núm. 8, pp. 887-892

  4. Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study

    International Journal of Clinical Pharmacy, Vol. 33, Núm. 3, pp. 582-589

2010

  1. Approach to establishing and evaluating clinical relevance of drugs interactions in HIV patients: 2009 update

    Farmacia Hospitalaria, Vol. 34, Núm. 2, pp. 90-93

2009

  1. Assessment of database results of pharmacist intervention

    Farmacia Hospitalaria

  2. Evaluation of a knowledge questionnaire about cardiovascular disease in Spanish community pharmacies

    Atencion Farmaceutica, Vol. 11, Núm. 2, pp. 101-109

2008

  1. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies

    Journal of Clinical Pharmacy and Therapeutics, Vol. 33, Núm. 5, pp. 475-481

  2. Documentation on role of pharmacist within healthcare: A pharmacotherapeutic history

    Farmacia Hospitalaria

  3. Light therapy: Its effectiveness in treating insomnia in elderly patients

    Atencion Primaria, Vol. 40, Núm. 2, pp. 101-103